Effect of VIA-2291 on Vascular Inflammation after ACS

ID Number 07-1060

Principal Investigator(s)
Michael E. Farkouh

Department(s) or Division(s)
Cardiology

Description

The purpose of this study is to determine the effect of VIA-2291 as compared to placebo on vascular inflammation following 24 weeks of dosing. ClinicalTrials.gov Identifier: NCT00552188

Contact Information
Kshitij Shah
(212) 659-8847
kshitij.shah@exchange.mssm.edu


Recruiting Patients: No